Cellromax Science Co., Ltd.
Research Cellromax Science Co., Ltd. (471820.KQ) on Bullrun: market cap KRW 43.59B, dividend yield 5.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker471820.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryPharmaceutical Retailers
- CurrencyKRW
- Market capKRW 43.59B
- Dividend yield5.0%
- Financial periodQ2 2026
- RevenueKRW 5.09B
- Net incomeKRW 804.21M
- Free cash flowKRW 1.31B
- Gross margin55.2%
Valuation Snapshot
latest market cap is KRW 43.59B; dividend yield is 5.0%.
Peer valuation comparison
Latest dividend yield is 5.04% versus a Healthcare sector median of 2.4% (110.0% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 43.59B | n/a | 5.0% | 200 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 200 KRW, yield 5.0%.
About Cellromax Science Co., Ltd.
Cellromax Science Co., Ltd. focuses to merge with other companies. The company was founded in 2022 and is based in Seoul, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Cellromax Science Co., Ltd.'s market cap?
Cellromax Science Co., Ltd.'s market capitalization is KRW 43.59B.
Does Cellromax Science Co., Ltd. pay a dividend?
Cellromax Science Co., Ltd. has a dividend yield of 5.0%.
What does Cellromax Science Co., Ltd. do?
Cellromax Science Co., Ltd. focuses to merge with other companies. The company was founded in 2022 and is based in Seoul, South Korea.